CD99 and Ewing sarcoma: The relative affinity of NOA2 was determined by flow cytometric saturation binding studies against five independent CD99-positive Ewing sarcoma cell lines (Figure 1B; Supplementary Figure S2 demonstrates replicates for A673, TC71, and TTC446).